Advanced search×

High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial.

J Infect Dis 203(6):756-64 (2011) PMID 21325137 PMCID PMC3071124

3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors (statins) exhibit antiviral activity against human immunodeficiency virus type 1 (HIV-1) in vitro and may modulate the immune response to HIV infection. Studies evaluating the antiviral activity of statins have yielded conflicting results.

DOI: 10.1093/infdis/jiq115
Version: za2963e q8zab q8zb4 q8zc7 q8zda q8ze2 q8zf7 q8zg6

Similar articles you may find interesting…

  1. HIV awareness and condom use among female sex workers in Afghanistan: implications for intervention.

    AIDS Care 23(3):348-56 (2011) PMID 21347898

    There is little information about HIV awareness or condom use among female sex workers (FSWs) in Afghanistan. The purpose of this cross-sectional study was to assess HIV awareness, knowledge, and condom use among FSWs in three Afghan cities. FSWs residing in Jalalabad, Kabul, and Maz...
  2. Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis.

    Am J Respir Crit Care Med 173(4):421-5 (2006) PMID 16272450

    B. dolosa chronic infection in cystic fibrosis is associated with accelerated loss of lung function and decreased survival....
  3. Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis: genome evolution, interactions and adaptation.

    Int J Med Microbiol 294(2-3):123-31 (2004) PMID 15493822

    The Gram-negative bacteria Pseudomonas aeruginosa and Burkholderia cepacia are opportunistic human pathogens that are responsible for severe nosocomial infections in immunocompromised patients and are the major pathogens in cystic fibrosis (CF). The two bacteria not only inhabit the same environment...